|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 06/05/15 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 29/04/15 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +0.65% | -3.56% | -12.32% | +14.23% | +57.11% | +33.53% | +60.50% | +5.04% | - | 63.48B | |
| +1.76% | +2.10% | -5.75% | +0.86% | +11.13% | +12.10% | +81.21% | +231.36% | +5,549.65% | 54.55B | |
| -0.94% | +0.77% | +10.65% | +12.58% | +17.11% | +8.85% | +100.19% | -16.58% | +256.22% | 53.59B | |
| +2.76% | +4.18% | +3.21% | +30.87% | +23.79% | +28.34% | +55.07% | +9.73% | +287.02% | 44.75B | |
| +2.00% | -2.90% | +3.47% | +14.56% | +22.89% | +18.37% | +119.04% | +1.66% | +1,037.95% | 41.62B | |
| +1.34% | -3.98% | -7.93% | +0.35% | +136.94% | +225.44% | +914.08% | +584.02% | - | 39.91B | |
| +0.64% | -3.85% | +6.99% | +6.21% | +10.10% | +11.71% | +45.57% | +5.41% | +152.66% | 32.47B | |
| +29.06% | +48.65% | +69.87% | +102.73% | +90.82% | +106.84% | +92.73% | +33.20% | +238.70% | 26.7B | |
| +3.72% | -7.45% | -12.60% | +19.81% | +47.33% | +24.25% | -2.99% | -60.58% | - | 23.36B | |
| +1.07% | -3.49% | -10.69% | -3.40% | -7.57% | -17.03% | -3.52% | -68.44% | - | 21.87B | |
| +2.13% | +1.37% | -17.69% | -7.40% | -44.28% | -40.87% | +306.11% | +267.35% | +604.80% | 20.74B | |
| +2.80% | +11.29% | +11.92% | +17.53% | +23.33% | +16.13% | +176.76% | +228.91% | +2,310.16% | 18.85B | |
| +4.22% | +18.55% | +27.71% | +66.73% | +87.48% | +91.51% | +116.69% | -13.04% | +388.99% | 17.13B | |
| +0.89% | +9.16% | +11.48% | +28.87% | +38.21% | +40.05% | +86.34% | -15.78% | +109.42% | 16.53B | |
| +1.42% | +2.94% | +13.96% | +18.76% | +51.22% | +65.74% | +228.12% | +211.17% | +506.96% | 16.19B | |
| +1.50% | +6.50% | +10.62% | -1.53% | - | - | - | - | - | 16.15B | |
| +0.84% | +3.90% | +3.90% | +0.42% | +183.22% | +163.59% | +345.61% | +1,418.19% | +787.21% | 15.21B | |
| -4.32% | -7.35% | -7.15% | -15.56% | +10.56% | +0.93% | +463.48% | - | - | 13.81B | |
| +17.04% | +22.95% | +24.27% | +26.89% | +17.53% | +17.65% | -8.99% | -23.99% | +166.10% | 14.12B | |
| Average | +3.58% | +1.76% | +6.52% | +17.55% | +43.16% | +44.84% | +176.45% | +164.57% | +953.53% | 27.55B | |
| Weighted average by Cap. | +3.02% | +0.89% | +4.05% | +16.71% | +41.10% | +43.41% | +167.67% | +130.58% | +1,264.34% |
- Stock Market
- Stocks
- Stock
- Sector Pharmacyclics, Inc.
Select your edition
All financial news and data tailored to specific country editions
